 BERKELEY HEIGHTS, N.J., April 04, 2022 GLOBE NEWSWIRE -- CorMedix Inc. Nasdaq: CRMD, a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that management will be presenting a corporate overview at the 21st Annual Needham Virtual Healthcare Conference being held April 11 14, 2022. 